• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

杜普伊特伦挛缩症。纤维化机制及其受类固醇调节的模型。

Dupuytren's disease. A model for the mechanism of fibrosis and its modulation by steroids.

作者信息

Meek R M, McLellan S, Crossan J F

机构信息

University Department of Orthopaedics, Western Infirmary, Glasgow, Scotland, UK.

出版信息

J Bone Joint Surg Br. 1999 Jul;81(4):732-8. doi: 10.1302/0301-620x.81b4.9163.

DOI:10.1302/0301-620x.81b4.9163
PMID:10463754
Abstract

Dupuytren's disease is a chronic inflammatory process which produces contractures of the fingers. The nodules present in Dupuytren's tissue contain inflammatory cells, mainly lymphocytes and macrophages. These express a common integrin known as VLA4. The corresponding binding ligands to VLA4 are vascular cell adhesion molecule-1 (VCAM-1) present on the endothelial cells and the CS1 sequence of the fibronectin present in the extracellular matrix. Transforming growth factor-beta (TGF-beta) is a peptide hormone which has a crucial role in the process of fibrosis. We studied tissue from 20 patients with Dupuytren's disease, four samples of normal palmar fascia from patients undergoing carpal tunnel decompression and tissue from ten patients who had received perinodular injections of depomedrone into the palm five days before operation. The distribution of VLA4, VCAM-1, CS1 fibronectin and TGF-beta was shown by immunohistochemistry using an alkaline phosphorylase method for light microscopy. In untreated Dupuytren's tissue CS1 fibronectin stained positively around the endothelial cells of blood vessels and also around the surrounding myofibroblasts, principally at the periphery of many of the active areas of the Dupuytren's nodule. VCAM-1 stained very positively for the endothelial cells of blood vessels surrounding and penetrating the areas of high nodular activity. VCAM-1 was more rarely expressed outside the blood vessels. VLA4 was expressed by inflammatory cells principally in and around the blood vessels expressing VCAM-1 and CS1 but also on some cells spreading into the nodule. TGF-beta stained positively around the inflammatory cells principally at the perivascular periphery of nodules. These cells often showed VLA4 expression and co-localised with areas of strong production of CS1 fibronectin. Normal palmar fascia contained only scanty amounts of CS1 fibronectin, almost no VCAM-1 and only an occasional cell staining positively for VLA4 or TGF-beta. In the steroid-treated group, VCAM-1 expression was downregulated in the endothelium of perinodular blood vessels and only occasional inflammatory cell expression remained. Expression of CS1 fibronectin was also much reduced but still occurred in the blood vessels and around the myofibroblast stroma. VLA4-expressing cells were also reduced in numbers. A similar but reduced distribution of production of TGF-beta was also noted. Our findings show that adherence of inflammatory cells to the endothelial wall and the extravasation into the periphery of the nodule may be affected by steroids, which reduce expression of VCAM-1 in vivo. This indicates that therapeutic intervention to prevent the recommencement of the chronic inflammatory process and subsequent fibrosis necessitating further surgery may be possible.

摘要

掌腱膜挛缩症是一种导致手指挛缩的慢性炎症过程。掌腱膜挛缩症组织中的结节含有炎症细胞,主要是淋巴细胞和巨噬细胞。这些细胞表达一种名为VLA4的常见整合素。VLA4的相应结合配体是内皮细胞上存在的血管细胞黏附分子-1(VCAM-1)以及细胞外基质中纤连蛋白的CS1序列。转化生长因子-β(TGF-β)是一种肽类激素,在纤维化过程中起关键作用。我们研究了20例掌腱膜挛缩症患者的组织、4例接受腕管减压手术患者的正常掌腱膜样本以及10例术前五天在手掌结节周围注射曲安奈德的患者的组织。采用碱性磷酸酶法进行免疫组织化学染色,通过光学显微镜观察VLA4、VCAM-1、CS1纤连蛋白和TGF-β的分布。在未经治疗的掌腱膜挛缩症组织中,CS1纤连蛋白在血管内皮细胞周围以及周围的肌成纤维细胞周围呈阳性染色,主要在掌腱膜挛缩症结节许多活跃区域的周边。VCAM-1在围绕并穿透高结节活性区域的血管内皮细胞上染色非常阳性。VCAM- 在血管外很少表达。VLA4主要由炎症细胞在表达VCAM-1和CS1的血管内及周围表达,但也在一些蔓延到结节内的细胞上表达。TGF-β在炎症细胞周围呈阳性染色,主要在结节的血管周围周边。这些细胞通常显示VLA4表达,并与CS1纤连蛋白大量产生的区域共定位。正常掌腱膜仅含有少量CS1纤连蛋白,几乎没有VCAM-1,只有偶尔的细胞对VLA4或TGF-β呈阳性染色。在类固醇治疗组中,结节周围血管内皮细胞中的VCAM-1表达下调,仅残留偶尔的炎症细胞表达。CS1纤连蛋白的表达也大幅降低,但仍在血管和肌成纤维细胞基质周围出现。表达VLA4的细胞数量也减少。还注意到TGF-β产生的分布类似但减少。我们的研究结果表明,炎症细胞与内皮壁的黏附以及向结节周边的渗出可能受到类固醇的影响,类固醇在体内会降低VCAM-1的表达。这表明有可能进行治疗干预以防止慢性炎症过程重新开始以及随后需要进一步手术的纤维化。

相似文献

1
Dupuytren's disease. A model for the mechanism of fibrosis and its modulation by steroids.杜普伊特伦挛缩症。纤维化机制及其受类固醇调节的模型。
J Bone Joint Surg Br. 1999 Jul;81(4):732-8. doi: 10.1302/0301-620x.81b4.9163.
2
Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.他莫昔芬可降低掌腱膜挛缩症患者掌腱膜中纤维母细胞的功能,并下调转化生长因子β2(TGF-β2)。
J Surg Res. 2002 Apr;103(2):146-52. doi: 10.1006/jsre.2001.6350.
3
Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?在掌腱膜挛缩症发病机制中促炎细胞因子和生长因子的作用:一种可能的未来治疗策略的新靶点?
Clin Sci (Lond). 2015 Oct 1;129(8):711-20. doi: 10.1042/CS20150088. Epub 2015 Jun 11.
4
Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.TGF-β1 刺激的 Dupuytren 成纤维细胞中 α-平滑肌肌动蛋白和细胞外基质成分被环 AMP 逆转。
BMC Musculoskelet Disord. 2011 May 25;12:113. doi: 10.1186/1471-2474-12-113.
5
Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.杜普伊特伦挛缩症成纤维细胞中骨形态发生蛋白的表达
J Hand Surg Am. 2004 Sep;29(5):809-14. doi: 10.1016/j.jhsa.2004.02.008.
6
Androgen receptors in Dupuytren's contracture.掌腱膜挛缩症中的雄激素受体。
J Orthop Res. 2002 Jan;20(1):163-8. doi: 10.1016/S0736-0266(01)00072-9.
7
Myofibroblast distribution in Dupuytren's cords: correlation with digital contracture.肌成纤维细胞在杜普伊特伦挛缩索带中的分布:与手指挛缩的相关性。
J Hand Surg Am. 2009 Dec;34(10):1785-94. doi: 10.1016/j.jhsa.2009.08.005. Epub 2009 Nov 11.
8
TGF beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin.与细胞活性、肌成纤维细胞表型以及纤连蛋白的癌胚变体相关的转化生长因子β和碱性成纤维细胞生长因子在掌腱膜挛缩症(结节性掌部纤维瘤病)中的合成与定位
Histochem J. 1995 Dec;27(12):1014-20.
9
Co-ordinate expression of alpha 5 beta 1 integrin and fibronectin in Dupuytren's disease.α5β1整合素与纤连蛋白在掌腱膜挛缩症中的协同表达
Acta Histochem. 1995 Jul;97(3):229-33. doi: 10.1016/S0065-1281(11)80184-4.
10
Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.在掌腱膜挛缩症临床受累和未受累手掌区域中组织学模式的识别。
PLoS One. 2014 Nov 7;9(11):e112457. doi: 10.1371/journal.pone.0112457. eCollection 2014.

引用本文的文献

1
A Case Report of Bilateral Plantar Fibromatosis and Review of Treatment Options.双侧足底纤维瘤病病例报告及治疗方案综述
Maedica (Bucur). 2023 Mar;18(1):136-142. doi: 10.26574/maedica.2023.18.1.136.
2
Effect of Oral Prednisolone after Collagenase Injection for Dupuytren's Contracture: A Randomized, Controlled Trial with a 1-Year Follow-Up.胶原酶注射治疗掌腱膜挛缩症后口服泼尼松龙的效果:一项为期1年随访的随机对照试验
J Hand Microsurg. 2020 Apr 13;14(2):113-120. doi: 10.1055/s-0040-1709097. eCollection 2022 Apr.
3
Intralesional fenestration and corticosteroid injection for symptomatic Ledderhose disease of the foot: Two case reports.
病灶内开窗术联合皮质类固醇注射治疗足部症状性莱德霍斯病:两例报告
SAGE Open Med Case Rep. 2021 Apr 28;9:2050313X211011813. doi: 10.1177/2050313X211011813. eCollection 2021.
4
Attenuation of Dupuytren's fibrosis via targeting of the STAT1 modulated IL-13Rα1 response.通过靶向信号转导和转录激活因子1(STAT1)调节的白细胞介素-13受体α1(IL-13Rα1)反应减轻杜普伊特伦挛缩症的纤维化
Sci Adv. 2020 Jul 10;6(28):eaaz8272. doi: 10.1126/sciadv.aaz8272. eCollection 2020 Jul.
5
Basics of Radiation Biology When Treating Hyperproliferative Benign Diseases.治疗增殖性良性疾病时的放射生物学基础
Front Immunol. 2017 May 3;8:519. doi: 10.3389/fimmu.2017.00519. eCollection 2017.
6
Clinical Results of Percutaneous Needle Fasciotomy for Dupuytren's Disease in Japanese Patients.日本患者掌腱膜挛缩症经皮针状筋膜切开术的临床结果
Plast Reconstr Surg Glob Open. 2015 Jun 5;3(5):e384. doi: 10.1097/GOX.0000000000000338. eCollection 2015 May.
7
The Rationale for Treating the Nodule in Dupuytren's Disease.治疗掌腱膜挛缩症中结节的理论依据。
Plast Reconstr Surg Glob Open. 2015 Jan 8;2(12):e278. doi: 10.1097/GOX.0000000000000249. eCollection 2014 Dec.
8
Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.解析促进杜普伊特伦挛缩症纤维化的信号通路揭示 TNF 作为治疗靶点。
Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):E928-37. doi: 10.1073/pnas.1301100110. Epub 2013 Feb 19.
9
Role of the HLA System in the Pathogenesis of Dupuytren's Disease.HLA系统在杜普伊特伦挛缩病发病机制中的作用。
Hand (N Y). 2010 Sep;5(3):241-50. doi: 10.1007/s11552-009-9255-y. Epub 2010 Feb 9.
10
Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.TGF-β1 刺激的 Dupuytren 成纤维细胞中 α-平滑肌肌动蛋白和细胞外基质成分被环 AMP 逆转。
BMC Musculoskelet Disord. 2011 May 25;12:113. doi: 10.1186/1471-2474-12-113.